IDEAYA Biosciences Inc.

NASDAQ: IDYA · Real-Time Price · USD
24.33
-0.04 (-0.16%)
At close: Aug 15, 2025, 3:59 PM
24.33
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

IDEAYA Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 7M n/a n/a n/a 3.92M 8.04M 3.54M 7.88M 4.02M 29.7M 5.85M 11.36M 2.96M 8.98M 8.76M 7.25M
Cost of Revenue
n/a n/a 643K n/a 1.1M 1.08M 1.02M 986K 998K 960K 558K 925K 1.2M 464K 425K 15.5M 14.98M 11.57M
Gross Profit
n/a n/a 6.36M n/a -1.1M -1.08M 2.9M 7.05M 2.55M 6.92M 3.46M 28.77M 4.65M 10.89M 2.54M -6.53M -6.22M -4.32M
Operating Income
-88.81M -84.39M -144.14M -66.89M -64.93M -51.02M -41.91M -33.53M -32.71M -26.28M -26.44M 660K -22.5M -14.22M -18.37M -11.71M -11.05M -9.13M
Interest Income
n/a 12.21M 13.83M 15.07M 12.15M 11.45M 7.96M 6.09M 4.78M 2.64M 2.24M 955K 443K 207K 157K 131K 104K 114K
Pretax Income
-77.49M -71.41M -130.31M -51.82M -52.77M -39.57M -33.95M -27.44M -27.93M -23.64M -24.2M 1.61M -22.06M -16.11M -18.21M -11.58M -10.95M -9.02M
Net Income
-77.49M -71.41M -130.31M -51.82M -52.77M -39.57M -33.95M -27.44M -27.93M -20.04M -21.96M 2.57M -21.61M -17.99M -18.21M -11.58M -10.95M -9.02M
Selling & General & Admin
14.58M 13.5M 10.96M 9.74M 9.3M 8.21M 7.07M 7.86M 7.08M 6.3M 5.75M 6.67M 5.55M 5.92M 5.22M 5.19M 4.83M 4.82M
Research & Development
74.23M 70.89M 140.18M 57.15M 54.53M 42.8M 38.77M 33.7M 29.18M 27.86M 24.71M 22.37M 22.8M 19.66M 16.11M 15.5M 14.98M 11.57M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.42M n/a n/a n/a
Operating Expenses
88.81M 84.39M 151.14M 66.89M 63.83M 51.02M 45.84M 41.56M 36.25M 34.16M 30.47M 29.04M 28.35M 25.58M 21.33M 20.69M 19.81M 16.38M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -1.1M n/a -1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 84.39M 151.14M 66.89M 64.93M 51.02M 45.84M 41.56M 36.25M 34.16M 30.47M 29.04M 28.35M 25.58M 21.33M 20.69M 19.81M 16.38M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -3.6M -2.24M -955K -443K 1.89M n/a n/a 44K n/a
Shares Outstanding (Basic)
88.47M 88.36M 87.34M 86.19M 77.96M 75.11M 65.25M 60M 56.25M 48.37M 48.13M 40.3M 38.66M 38.59M 38.36M 37.36M 32.85M 31.76M
Shares Outstanding (Diluted)
88.47M 88.36M 87.34M 86.19M 77.96M 75.11M 65.25M 60M 56.25M 48.37M 48.13M 41.11M 38.66M 38.59M 38.5M 37.77M 32.85M 31.76M
EPS (Basic)
-0.88 -0.82 -1.49 -0.6 -0.68 -0.53 -0.52 -0.46 -0.5 -0.41 -0.46 0.06 -0.56 -0.47 -0.47 -0.31 -0.33 -0.28
EPS (Diluted)
-0.88 -0.82 -1.49 -0.6 -0.68 -0.53 -0.52 -0.46 -0.5 -0.41 -0.46 0.06 -0.56 -0.47 -0.47 -0.31 -0.33 -0.28
EBITDA
-88.81M -83.26M -143.5M -66.89M -64.31M -50.4M -41.29M -32.89M -32.09M -25.69M -25.89M 1.58M -21.64M -13.76M -17.79M -11.26M -10.61M -8.75M
EBIT
-77.49M -84.39M -144.14M -66.89M -64.93M -51.02M -41.92M -33.53M -32.71M -26.28M -26.44M 660K -22.5M -14.22M -18.37M -11.71M -11.05M -9.13M
Depreciation & Amortization
n/a 1.13M 643K 1.01M 1.1M 1.08M 1.02M 986K 998K 960K 558K 925K 1.2M 464K 425K 500K 400K 382K